SO-010 - Preliminary results in colorectal cancer (CRC) patients enrolled in the GATTO study, a phase I study of Tomuzotuximab in combination with Gatipotuzumab in patients with EGFR positive solid tumors. - Garralda, E.; Fiedler, W.; Matos, I.; Rolling, C.; Kebenko, M.; Klinghammer, K.; Conte, G.; Raspagliesi, F.; Habel, B.; Baumeister, H.; Ochsenreither, S.; Zurlo, A. (Annals of Oncology, 2019)